A retrospective gender-comparative evaluation of the prognostic factors in differentiated thyroid cancers

Volume: 56 Number: 2 July 1, 2017
  • Mustafa Demirpençe
  • Hamiyet Yılmaz
  • Pelin Tütüncüoğlu
  • Ahmet Görgel
  • Mithat Bahçeci
Ege Journal of Medicine Cover
Ege Journal of Medicine
PDF Download
EN TR

A retrospective gender-comparative evaluation of the prognostic factors in differentiated thyroid cancers

Abstract

Aim: Differentiated thyroid cancers are the most common endocrine cancer types among all. Differentiated thyroid cancers are more common with women, but the prognosis tends to be poorer in men. This study aims to compare prognostic factors between genders in the patients who are being treated with a differentiated thyroid cancer diagnosis in İzmir Atatürk Research and Training Hospital Endocrinology Department. Materials and Methods: The 458 patients who were treated with a diagnosis of differentiated thyroid carcinoma in our department were included in this retrospective study. Results: Sixty-eight (14.8%) of the patients were male and 390 (85.2%) of the patients were female. The mean age of the patients included in the study was 49.8 (±12.6) at the time of diagnosis. The mean age of the male and female patients were 54.6 (±13.6) and 48.9 (±12.2), respectively (p

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Mustafa Demirpençe

Hamiyet Yılmaz

Pelin Tütüncüoğlu

Ahmet Görgel

Mithat Bahçeci

Publication Date

July 1, 2017

Submission Date

July 1, 2017

Acceptance Date

-

Published in Issue

Year 2017 Volume: 56 Number: 2

DOI

https://doi.org/10.19161/etd.344241

IZ

https://izlik.org/JA25SD37RP

Cite

RIS / Bibtex
Vancouver
1.Mustafa Demirpençe, Hamiyet Yılmaz, Pelin Tütüncüoğlu, Ahmet Görgel, Mithat Bahçeci. Diferansiye tiroid kanserlerinde prognostik faktörlerin cinsiyetler arasında karşılaştırmalı olarak retrospektif değerlendirilmesi. EJM. 2017 Jul. 1;56(2):62-5. doi:10.19161/etd.344241

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.